Jim Wassil's most recent trade in Vaxcyte Inc was a trade of 18,000 shares done at an average price of $5.4 . Disclosure was reported to the exchange on Oct. 5, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vaxcyte Inc | Mr. Jim Wassil | EVP, Chief Scientific Ofc, COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.35 per share. | 05 Oct 2026 | 18,000 | 163,435 | - | 5.4 | 96,300 | - |
| Vaxcyte Inc | Mr. Jim Wassil | EVP, Chief Scientific Ofc, COO | Sale of securities on an exchange or to another person at price $ 86.74 per share. | 05 Oct 2026 | 18,000 | 145,435 | - | 86.7 | 1,561,320 | - |
| Vaxcyte Inc | Mr. Jim Wassil | EVP, Chief Scientific Ofc, COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.35 per share. | 01 Oct 2026 | 2,250 | 147,685 | - | 5.4 | 12,038 | - |
| Vaxcyte Inc | Mr. Jim Wassil | EVP, Chief Scientific Ofc, COO | Sale of securities on an exchange or to another person at price $ 56.65 per share. | 01 Oct 2026 | 2,155 | 145,530 | - | 56.7 | 122,089 | - |
| Vaxcyte Inc | Mr. Jim Wassil | EVP, Chief Scientific Ofc, COO | Sale of securities on an exchange or to another person at price $ 57.09 per share. | 01 Oct 2026 | 95 | 145,435 | - | 57.1 | 5,424 | - |
| Vaxcyte Inc | Mr. Jim Wassil | EVP, Chief Scientific Ofc, COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.36 per share. | 04 Sep 2026 | 5,459 | 146,769 | - | 60.4 | 329,505 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | EVP, Chief Scientific Ofc, COO | Sale of securities on an exchange or to another person at price $ 61.16 per share. | 04 Sep 2026 | 1,381 | 152,228 | - | 61.2 | 84,462 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | EVP, Chief Scientific Ofc, COO | Sale of securities on an exchange or to another person at price $ 59.52 per share. | 04 Sep 2026 | 1,334 | 145,435 | - | 59.5 | 79,401 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.35 per share. | 31 Aug 2026 | 2,250 | 158,518 | - | 5.4 | 12,038 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | 31 Aug 2026 | 2,250 | 66,648 | - | - | Stock Option (right to buy) | ||
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 60.89 per share. | 31 Aug 2026 | 1,537 | 156,981 | - | 60.9 | 93,582 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.58 per share. | 31 Aug 2026 | 1,432 | 153,609 | - | 61.6 | 88,183 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.74 per share. | 31 Aug 2026 | 1,273 | 156,268 | - | 60.7 | 77,322 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 60.95 per share. | 31 Aug 2026 | 924 | 155,344 | - | 61.0 | 56,322 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 61.48 per share. | 31 Aug 2026 | 713 | 156,268 | - | 61.5 | 43,836 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 61.42 per share. | 31 Aug 2026 | 303 | 155,041 | - | 61.4 | 18,611 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | 03 Aug 2026 | 2,250 | 68,898 | - | - | Stock Option (right to buy) | ||
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.35 per share. | 03 Aug 2026 | 2,250 | 159,791 | - | 5.4 | 12,038 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 54.09 per share. | 03 Aug 2026 | 1,389 | 157,541 | - | 54.1 | 75,130 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 53.50 per share. | 03 Aug 2026 | 861 | 158,930 | - | 53.5 | 46,065 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 56.03 per share. | 01 Jul 2026 | 1,788 | 157,222 | - | 56.0 | 100,182 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | 01 Jul 2026 | 516 | 71,148 | - | - | Stock Option (right to buy) | ||
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.35 per share. | 01 Jul 2026 | 516 | 159,010 | - | 5.4 | 2,761 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 57.47 per share. | 01 Jul 2026 | 456 | 156,766 | - | 57.5 | 26,208 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 57.83 per share. | 01 Jul 2026 | 6 | 156,760 | - | 57.8 | 347 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 49.40 per share. | 01 Jun 2026 | 1,949 | 158,795 | - | 49.4 | 96,288 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 50.26 per share. | 01 Jun 2026 | 301 | 158,494 | - | 50.3 | 15,127 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 56.83 per share. | 01 May 2026 | 2,250 | 160,744 | - | 56.8 | 127,870 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 58.14 per share. | 01 Apr 2026 | 1,412 | 165,406 | - | 58.1 | 82,091 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 58.93 per share. | 01 Apr 2026 | 838 | 162,994 | - | 58.9 | 49,385 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 59.16 per share. | 09 Mar 2026 | 4,968 | 166,818 | - | 59.2 | 293,907 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 59.16 per share. | 09 Mar 2026 | 4,968 | 166,818 | - | 59.2 | 293,907 | - |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 58.32 per share. | 09 Mar 2026 | 2,427 | 171,786 | - | 58.3 | 141,533 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 58.32 per share. | 09 Mar 2026 | 2,427 | 171,786 | - | 58.3 | 141,533 | - |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.32 per share. | 09 Mar 2026 | 975 | 174,213 | - | 59.3 | 57,837 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.32 per share. | 09 Mar 2026 | 975 | 174,213 | - | 59.3 | 57,837 | - |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | 26 Feb 2026 | 53,566 | 53,566 | - | - | Stock Option (right to buy) | ||
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 32,045 | 173,893 | - | 0 | Common Stock | |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 32,045 | 173,893 | - | 0 | - | |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 61.74 per share. | 26 Feb 2026 | 5,102 | 178,995 | - | 61.7 | 314,997 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 61.74 per share. | 26 Feb 2026 | 5,102 | 178,995 | - | 61.7 | 314,997 | - |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.74 per share. | 26 Feb 2026 | 1,900 | 177,095 | - | 61.7 | 117,306 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.74 per share. | 26 Feb 2026 | 1,900 | 177,095 | - | 61.7 | 117,306 | - |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.98 per share. | 26 Feb 2026 | 1,009 | 175,188 | - | 62.0 | 62,538 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.98 per share. | 26 Feb 2026 | 1,009 | 175,188 | - | 62.0 | 62,538 | - |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.98 per share. | 26 Feb 2026 | 898 | 176,197 | - | 62.0 | 55,658 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.98 per share. | 26 Feb 2026 | 898 | 176,197 | - | 62.0 | 55,658 | - |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.41 per share. | 08 Sep 2025 | 2,759 | 141,848 | - | 32.4 | 89,419 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.41 per share. | 08 Sep 2025 | 2,759 | 141,848 | - | 32.4 | 89,419 | - |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.56 per share. | 02 Sep 2025 | 1,587 | 147,699 | - | 31.6 | 50,086 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.56 per share. | 02 Sep 2025 | 1,587 | 147,699 | - | 31.6 | 50,086 | - |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.56 per share. | 02 Sep 2025 | 1,429 | 146,270 | - | 31.6 | 45,099 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.56 per share. | 02 Sep 2025 | 1,429 | 146,270 | - | 31.6 | 45,099 | - |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.56 per share. | 02 Sep 2025 | 1,270 | 149,286 | - | 31.6 | 40,081 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.56 per share. | 02 Sep 2025 | 1,270 | 149,286 | - | 31.6 | 40,081 | - |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | 27 Feb 2025 | 72,536 | 72,536 | - | - | Stock Option (right to buy) | ||
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 21,726 | 153,421 | - | 0 | Common Stock | |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 21,726 | 153,421 | - | 0 | - | |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 73.07 per share. | 27 Feb 2025 | 5,915 | 157,016 | - | 73.1 | 432,215 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 73.07 per share. | 27 Feb 2025 | 5,915 | 157,016 | - | 73.1 | 432,215 | - |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 73.02 per share. | 27 Feb 2025 | 5,649 | 159,070 | - | 73.0 | 412,490 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 73.02 per share. | 27 Feb 2025 | 5,649 | 159,070 | - | 73.0 | 412,490 | - |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | 27 Feb 2025 | 5,362 | 71,664 | - | - | Stock Option (right to buy) | ||
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.35 per share. | 27 Feb 2025 | 5,362 | 162,931 | - | 5.4 | 28,687 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.35 per share. | 27 Feb 2025 | 5,362 | 162,931 | - | 5.4 | 28,687 | - |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.10 per share. | 27 Feb 2025 | 3,015 | 151,916 | - | 72.1 | 217,382 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.10 per share. | 27 Feb 2025 | 3,015 | 151,916 | - | 72.1 | 217,382 | - |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.02 per share. | 27 Feb 2025 | 2,869 | 156,201 | - | 73.0 | 209,494 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.02 per share. | 27 Feb 2025 | 2,869 | 156,201 | - | 73.0 | 209,494 | - |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | 27 Feb 2025 | 2,638 | 0 | - | - | Stock Option (right to buy) | ||
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.42 per share. | 27 Feb 2025 | 2,638 | 157,569 | - | 2.4 | 6,384 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.42 per share. | 27 Feb 2025 | 2,638 | 157,569 | - | 2.4 | 6,384 | - |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 73.84 per share. | 27 Feb 2025 | 2,085 | 154,931 | - | 73.8 | 153,950 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 73.84 per share. | 27 Feb 2025 | 2,085 | 154,931 | - | 73.8 | 153,950 | - |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.02 per share. | 27 Feb 2025 | 1,270 | 154,931 | - | 73.0 | 92,735 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.02 per share. | 27 Feb 2025 | 1,270 | 154,931 | - | 73.0 | 92,735 | - |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | 03 Feb 2025 | 8,000 | 2,638 | - | - | Stock Option (right to buy) | ||
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.42 per share. | 03 Feb 2025 | 8,000 | 213,695 | - | 2.4 | 19,360 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.42 per share. | 03 Feb 2025 | 8,000 | 213,695 | - | 2.4 | 19,360 | - |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 86.00 per share. | 03 Feb 2025 | 5,314 | 208,381 | - | 86.0 | 456,983 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 86.00 per share. | 03 Feb 2025 | 5,314 | 208,381 | - | 86.0 | 456,983 | - |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 86.67 per share. | 03 Feb 2025 | 2,666 | 205,715 | - | 86.7 | 231,049 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 86.67 per share. | 03 Feb 2025 | 2,666 | 205,715 | - | 86.7 | 231,049 | - |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 87.95 per share. | 03 Feb 2025 | 20 | 205,695 | - | 88.0 | 1,759 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 87.95 per share. | 03 Feb 2025 | 20 | 205,695 | - | 88.0 | 1,759 | - |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.42 per share. | 02 Jan 2025 | 8,000 | 213,695 | - | 2.4 | 19,360 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | 02 Jan 2025 | 8,000 | 10,638 | - | - | Stock Option (right to buy) | ||
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.42 per share. | 02 Jan 2025 | 8,000 | 213,695 | - | 2.4 | 19,360 | - |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 83.69 per share. | 02 Jan 2025 | 5,483 | 206,856 | - | 83.7 | 458,861 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 83.69 per share. | 02 Jan 2025 | 5,483 | 206,856 | - | 83.7 | 458,861 | - |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 82.88 per share. | 02 Jan 2025 | 1,356 | 212,339 | - | 82.9 | 112,381 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 82.88 per share. | 02 Jan 2025 | 1,356 | 212,339 | - | 82.9 | 112,381 | - |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 84.43 per share. | 02 Jan 2025 | 1,161 | 205,695 | - | 84.4 | 98,024 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 84.43 per share. | 02 Jan 2025 | 1,161 | 205,695 | - | 84.4 | 98,024 | - |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2024 | 74,000 | 131,695 | - | 0 | Common Stock | |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | 02 Dec 2024 | 8,000 | 18,638 | - | - | Stock Option (right to buy) | ||
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.42 per share. | 02 Dec 2024 | 8,000 | 213,695 | - | 2.4 | 19,360 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 92.07 per share. | 02 Dec 2024 | 5,772 | 207,923 | - | 92.1 | 531,416 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 94.06 per share. | 02 Dec 2024 | 1,127 | 205,695 | - | 94.1 | 106,008 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 93.06 per share. | 02 Dec 2024 | 1,101 | 206,822 | - | 93.1 | 102,460 | Common Stock |
| Vaxcyte Inc | Mr. Jim Wassil | CHIEF OPERATING OFFICER | 07 Nov 2024 | 87,481 | 87,481 | - | - | Performance Stock Option (right to buy) |